D-0588-2026 Class II Ongoing

Recalled by Glenmark Pharmaceuticals Inc., USA — Elmwood Park, NJ

Recall Details

Product Type
Drugs
Report Date
June 24, 2026
Initiation Date
May 27, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister Cards each containing 28 tablets, 28 day regimen, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Colvale-Bardez, Goa 403 513, India, Manufactured for: Glenmark Pharmaceuticals Inc., Mahwah, NJ 07430, NDC 68462-556-29

Reason for Recall

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Distribution Pattern

USA Nationwide.

Code Information

Lot #: 20240411, Exp: 6/30/2026; 20250252, Exp: 3/31/2027